Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma

Publisher： Karger

E-ISSN： 1423-0232|92|4|229-242

ISSN： 0030-2414

Source： Oncology, Vol.92, Iss.4, 2017-02, pp. : 229-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Macrophage chemotactic protein-1 mRNA levels in non-Hodgkin lymphoma

By Valković Toni   Duletić-Načinović Antica   Štifter Sanja   Hasan Milena   Hadžisejdić Ita   Zombori David   Grahovac Blaženka   Jonjić Nives  

Clinical and Experimental Medicine, Vol. 10, Iss. 4, 2010-12 ,pp. : 229-235

Springer Publishing Company

Access to resources Recommend Favorite

NON‐HODGKIN'S LYMPHOMA IN THE OLD OLD

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 43, Iss. 7, 1995-07 ,pp. : 837-837

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epidemiology of Non-Hodgkin's Lymphoma in India

By  

Oncology, Vol. 91, Iss. 1, 2016-07 ,pp. : 18-25

Karger

Access to resources Recommend Favorite

Antibody Therapy with Rituximab for Patients with Low-Grade Non-Hodgkin’s Lymphoma

By  

Oncology Research and Treatment, Vol. 22, Iss. 3, 1999-07 ,pp. : 184-190

Karger

Access to resources Recommend Favorite

99mTc-labeled butyl-substituted zoledronic acid as a novel potential SPECT imaging agent: preparation and preclinical pharmacology study

By Qiu Ling   Lin Jianguo   Cheng Wen   Wang Yan   Luo Shineng  

Medicinal Chemistry Research, Vol. 22, Iss. 12, 2013-12 ,pp. : 6154-6162

Springer Publishing Company

Access to resources Recommend Favorite